Skip to main content

Pharma

By Jessica Hagen | 05:09 pm | June 26, 2025
The company offers an AI-enabled workflow automation platform for administrative tasks pertaining to specialty medications. 
By Anthony Vecchione | 02:07 pm | June 11, 2025
Amino Health's navigation platform will provide health plans, third-party administrators, government agencies and health systems with tools to manage pharmacy and medical benefits.    
By Jessica Hagen | 12:42 pm | May 21, 2025
The AI-powered COPD care coordination tool uses EHR data and natural language processing to identify and manage high-risk patients.
HIMSS25
By HIMSS TV | 11:56 am | May 20, 2025
Genetic therapy is effective but can cost millions of dollars. Boro Dropulić, executive director of Caring Cross, says technology innovations and partnerships with hospitals and governments can help lower costs and increase accessibility.
By Adam Ang | 01:17 am | May 08, 2025
It joins Lunit and Us2.ai in the vendor-neutral, cloud-based marketplace of medical AI solutions.
HIMSS25
By HIMSS TV | 05:10 pm | April 30, 2025
Michele Krajewski, HIMSS' Global Health Conference Education Committee chair, explains how the committee ensures each year's conference curriculum reflects the interests and needs of HIMSS' diverse membership.
By Jessica Hagen | 03:58 pm | April 30, 2025
Americans with a prescription will have access to Novo Nordisk's obesity drug Wegovy through the Hims & Hers platform for $599 monthly.
By Jessica Hagen | 12:42 pm | April 29, 2025
Juan Lavista Ferres, CVP and chief data scientist at Microsoft's AI for Good Lab, and Meghana Kshirsagar, senior research scientist, discuss their research on protein symmetry.
By Anthony Vecchione | 02:29 pm | April 25, 2025
Lilly accuses four compounders of selling unauthorized versions of the pharma giant's diabetes and weight-loss drugs.
By HIMSS TV | 11:10 am | April 24, 2025
Michael Ramey, managing principal of Strategic & Transaction Solutions at PYA says due to changes in the FTC's new premerger notification rules, he's advising clients to be prepared to disclose more information and undergo greater scrutiny.